Nurse Practitioner · Chicago, IL
NPI
1467848366
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
225 E Chicago Ave
Chicago, IL, 60611
Phone (312) 227-6763
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$606K
86 prescriptions
Company payments, 2025
$17K
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Erika R Vucko prescribed most often to Medicare patients was Sapropterin Dihydrochloride, with 26 prescriptions and refills. In total Erika R Vucko wrote 86 Medicare prescriptions that cost $606K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sapropterin Dihydrochloride Generic | 26 | 26 | Under 11 | $113K |
| Javygtor Sapropterin Dihydrochloride | 22 | 22 | Under 11 | $157K |
| Palynziq Pegvaliase-Pqpz | 12 | 12 | Under 11 | $224K |
Brand drugs: 18 claims; generic drugs: 68 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erika R Vucko $17K ($17K in general payments such as food, travel and fees) from 10 companies. The largest payer was BioMarin Pharmaceutical Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. BMRN | 18 | $12K |
| PTC Therapeutics, Inc. PTCT | 7 | $2,333 |
| Amgen Inc. AMGN | 2 | $875 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 8 | $867 |
| Chiesi USA, Inc. | 2 | $600 |
| Cycle Pharmaceuticals Inc | 2 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $44.13 |
| Zevra Therapeutics Inc ZVRA | 1 | $43.04 |
| Eton Pharmaceuticals, Inc. ETON | 1 | $15.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.